New Ebola treatment increases survival rates in mice

Novel Ebola treatment increases survival in mice
Novel Ebola treatment increases survival in mice | Courtesy of

Researchers have shown that an experimental treatment for Ebola increased the survival rates of tested mice as scientists continue searching for ways the global health community can be better prepared for any future outbreaks.  

The Ebola outbreak began in West Africa in December 2013 and claimed 10,000 lives. Approximately 25,000 people were infected with the disease before it slowed its spread.

The Food and Drug Administration (FDA) has not approved any vaccine or therapeutic drug that may treat Ebola. Some scientists have created vaccines that may prevent future Ebola infections, while others are concentrating on treatments for patients who have already contracted the disease. Some of the investigational compounds include flu and malaria drugs.

One group of researchers have focused on a class of diazachrysenes, which are small, non-toxic molecules that effectively treat botulinum neurotoxin,  the most serious bacterial toxin. Scientists want to screen this class for potential Ebola drug candidates.

Researchers have discovered potential drug candidates for a new Ebola treatment that successfully increase the survival rates of 70 to 90 percent of mice subjects.

Further details about the study are available in ACS Infectious Diseases journal.

Organizations in this Story

FDA Office of Medical Products and Tobacco

Get notified the next time we write about FDA Office of Medical Products and Tobacco!